No Association of Hypoxia Inducible Factor-1α Gene Polymorphisms with Breast Cancer in North-West Indians |
Sharma, Sarika
(Human Cytogenetics Laboratory, Department of Human Genetics, Guru Nanak Dev University)
Kapahi, Ruhi (Human Cytogenetics Laboratory, Department of Human Genetics, Guru Nanak Dev University) Sambyal, Vasudha (Human Cytogenetics Laboratory, Department of Human Genetics, Guru Nanak Dev University) Guleria, Kamlesh (Human Cytogenetics Laboratory, Department of Human Genetics, Guru Nanak Dev University) Manjari, Mridu (Department of Pathology, Sri Guru Ram Das Institute of Medical Sciences and Research) Sudan, Meena (Department of Radiotherapy, Sri Guru Ram Das Institute of Medical Sciences and Research) Uppal, Manjit Singh (Department of Surgery, Sri Guru Ram Das Institute of Medical Sciences and Research) Singh, Neeti Rajan (Department of Surgery, Sri Guru Ram Das Institute of Medical Sciences and Research) |
1 | Adeli K, Ogbonna G (1990). Rapid purification of human DNA from whole blood for potential application in clinical chemistry laboratories. Clin Chem, 36, 261-4. |
2 | Apaydin I, Konac E, Onen HI, et al (2008). Single nucleotide polymorphisms in the hypoxia- inducible factor- (HIF- ) gene in human sporadic breast cancer. Arch Med Res, 39, 338-45. DOI |
3 | Bhasin MK, Walter H, Danker-Hopfe H, Kamla-Raj Publishers; New Delhi: 1992. The distribution of genetical, morphological and behavioral traits among the peoples on Indian region. |
4 | Bos R, Zhong H, Hanrahan CF, et al (2001). Levels of hypoxiainducible factor- during breast carcinogenesis. J Natl Cancer Inst, 93, 309-14. DOI ScienceOn |
5 | Carrero P, Okamoto K, Coumalleau P, et al (2000). Redoxregulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor . Mol Cell Biol, 20, 402-15. DOI ScienceOn |
6 | Chau CH, Permenter MG, Steinberg SM, et al (2005). Polymorphism in the hypoxia-inducible factor 1 alpha gene may confer susceptibility to androgen-independent prostate cancer. Cancer Biol Ther, 4, 1222-5. |
7 | Foley R, Marignol L, Thomas AZ, et al (2009). The HIF- C1772T polymorphism may be associated with susceptibility to clinically localized prostate cancer but not with elevated expression of hypoxic biomarkers. Cancer Biol Ther, 8, 118-24. DOI |
8 | Fransen K, Fenech M, Fredrikson M, Dabrosin C, Soderkvist P (2006). Association between ulcerative growth and hypoxia inducible Factor-1 alpha polymorphisms in colorectal cancer Patients. Mol Carcinog, 45, 833-40. DOI |
9 | Hanahan D, Weinberg RA (2011). Hallmarks of cancer: the next generation. Cell, 144, 646-74. DOI ScienceOn |
10 | He P, Han Q, Liu J, et al (2013). The association between Hypoxia-Inducible Factor- gene C1772T polymorphism and cancer risk: A Meta-analysis of 37 case-control studies. PLoS One, 8, 83441. DOI |
11 | Hill RP, Marie-Egyptienne DT, Hedley DW (2009). Cancer stem cells, hypoxia and metastasis. Semin Radia Oncol, 19, 106-11. DOI |
12 | Hsiao PC, Chen MK, Su SC, et al (2010). Hypoxia inducible factor-1alpha gene polymorphism G1790A and its interaction with tobacco and alcohol consumptions increase susceptibility to hepatocellular carcinoma. J Surg Oncol, 102, 163-9. DOI |
13 | Hu X, Fang Y, Zheng J, et al (2014). The association between HIF- polymorphism and cancer risk: a systematic review and meta-analysis. Tumour Biol, 35, 903-16. DOI |
14 | Jiang BH, Rue E, Wang GL, Roe R, Semenza GL (1996). Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem, 271, 17771-8. DOI ScienceOn |
15 | Kim HO, Jo YH, Lee J, Lee SS, Yoon KS (2008). The C1772T genetic polymorphism in human HIF- gene associates with expression of HIF- protein in breast cancer. Oncol Rep, 20, 1181-87. |
16 | Li K, Zhang Y, Dan Z, Wang Y, Ren ZC (2009). Association of the Hypoxia Inducible Factor- gene polymorphisms with gastric cancer in Tibetans. Biochem Genet, 47, 625-34. DOI |
17 | Konac E, Onen HI, Metindir J, et al (2007). An investigation of relationships between hypoxia-inducible factor- gene polymorphisms and ovarian, cervical and endometrial cancers. Cancer Detect Prev, 31, 102-9. DOI |
18 | Lee JY, Choi JY, Lee KM, et al (2008). Rare variant of hypoxiainducible factor- (HIF-1A) and breast cancer risk in Korean women. Clin Chim Acta, 389, 167-70. DOI |
19 | Li D, Liu J, Zhang W, et al (2013). Association between HIF1A P582S and A588T polymorphisms and the risk of urinary cancers: a meta-analysis. PLoS One, 8, 63445. DOI |
20 | Ling TS, Shi RS, Zhang GX, et al (2005). Common single nucleotide polymorphism of hypoxia inducible factor- and its impact on the clinicopathological features of esophageal squamous cell carcinoma. Chin J Dig Dis, 6, 155-8. DOI |
21 | Medeiros R, Vasconcelos A, Costa S, et al (2003). Steroid hormone genotypes ARStuI and ER325 are linked to the progression of human prostate cancer. Cancer Genet Cytogenet, 141, 91-6. DOI |
22 | Medeiros R, Vasconcelos A, Costa S, et al (2004). Linkage of angiotensin I-converting enzyme gene insertion/deletion polymorphism to the progression of human prostate cancer. J Pathol, 202, 330-5. DOI |
23 | Munoz-Guerra MF, Fernandez-Contreras ME, Moreno AL, et al (2009). Polymorphisms in the hypoxia inducible factor and the impact on the prognosis of early stages of oral cancer. Ann Surg Oncol, 16, 2351-58. DOI |
24 | Pinto D, Vasconcelos A, Costa S, et al (2004). HER2 polymorphism and breast cancer risk in Portugal. Eur J Cancer Prev, 13, 177-81. DOI |
25 | Naidu R, Har YC, Taib NA (2009). Associations between hypoxia-inducible factor- (HIF-) gene polymorphisms and risk of developing breast cancer. Neoplasma, 56, 441-7. DOI |
26 | Newcomb EW, Zagzag D (2009). HIF-1 regulation of chemokine receptor expression. chemokine receptors in cancer. in 'cancer drug discovery and development', eds, Fulton AM. Springer link pp 47-61. |
27 | Ollerenshaw M, Page T, Hammonds J, Demaine A (2004). Polymorphisms in the hypoxia inducible factor-1 alpha gene (HIF1A) are associated with the renal cell carcinoma phenotype. Cancer Genet Cytogenet, 153, 122-6. DOI |
28 | Poon E, Harris AL, Ashcroft (2009). Targeting the hypoxiainducible factor (HIF) pathway in cancer. Expert Rev Mol Med, 11, 26. DOI |
29 | Pouyssegur J, Dayan F, Mazure NM (2006). Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature, 441, 437-43. DOI ScienceOn |
30 | Rankin EB, Giaccia AJ (2008). The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ, 15, 678-85. DOI ScienceOn |
31 | Ribeiro AL, Correia J, Ribeiro V (2009). Ethnic variability of HIF-1alpha polymorphisms. Cancer Biomark, 5, 273-7. |
32 | Ruan K, Song G, Ouyang G (2009). Role of hypoxia in the hallmarks of human cancer. J Cell Biochem, 107: 1053-62. DOI ScienceOn |
33 | Semenza GL, Wang GL (1992). A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol, 12, 5447-54. |
34 | Santos AM, Sousa H, Pinto D, et al (2006). Linking TP53 codon 72 and P21 nt590 genotypes to the development of cervical and ovarian cancer. Eur J Cancer, 42, 958-63. DOI |
35 | Schoppmann SF, Horvat R, Birner P (2002). Lymphatic vessels and lymphangiogenesis in female cancer: mechanisms, clinical impact and possible implications for antilymphangiogenic therapies (Review). Oncol Rep, 9, 455-60. |
36 | Semenza GL (2003). Targeting HIF-1 for cancer therapy. Nat Rev Cancer, 3, 721-32. DOI ScienceOn |
37 | Smaldone MC, Maranchie JK (2009). Clinical implications of hypoxia inducible factor in renal cell carcinoma. Urol Oncol, 27, 238-45. DOI |
38 | Sorlie T, Perou CM, Tibshirani R, et al (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA, 98, 10869-74. DOI ScienceOn |
39 | Talks K L, Turley H, Gatter KC, et al (2000). The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2 alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol, 157, 411-21. DOI ScienceOn |
40 | Tanimoto K, Yoshiga K, Eguchi H, et al (2003). Hypoxiainducible factor-1 alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis, 24, 1779-83. DOI |
41 | Wu G, Yan WF, Zhu YZ, Sun PC (2014). Hypoxia-inducible factor- (HIF-) C1772T polymorphism significantly contributes to the risk of malignancy from a meta-analysis. Tumour Biol, 35, 4113-22. DOI |
42 | Vainrib M, Golan M, Amir S, et al (2012). HIF1A C1772T polymorphism leads to HIF- mRNA overexpression in prostate cancer patients. Cancer Biol Ther, 13, 720-6. DOI |
43 | Wang X, Liu Y, Ren H, et al (2011). Polymorphisms in the hypoxia-inducible factor- gene confer susceptibility to pancreatic cancer. Cancer Biol Ther, 12, 383-7. DOI |
44 | Wenger RH, Stiehl DP, Camenisch G (2005). Integration of oxygen signaling at the consensus HRE. Sci STKE, re12. |
45 | Xu G, Wang M, Xie W, Bai X (2011). Hypoxia-inducible factor-1 alpha C1772T gene polymorphism and glioma risk: a hospital-based case-control study from China. Genet Test Mol Biomarkers, 15, 461-4. DOI |
46 | Zagouri F, Sergentanis TN, Gazouli M, et al (2012). HSP90, HSPA8, HIF-1 alpha and HSP70-2 polymorphisms in breast cancer: a case-control study. Mol Biol Rep, 39, 10873-9. DOI |
47 | Zhang Q, Chen Y, Zhang B, et al (2013). Hypoxia-inducible factor- polymorphisms and risk of cancer metastasis: a meta-analysis. PLoS One, 8, 70961. DOI |
48 | Zhong H, De Marzo AM, Laughner E, et al (1999) Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases. Cancer Res, 59, 5830-35. |
49 | Zhou Y, Lin L, Wang Y, et al (2014). The association between hypoxia-inducible factor- gene G1790A polymorphism and cancer risk: a meta-analysis of 28 case-control studies. Cancer Cell Int, 14, 37. DOI |